34,507 Intuitive Surgical, Inc. $ISRG Shares Purchased by Vestor Capital LLC

Vestor Capital LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 299.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 46,043 shares of the medical equipment provider’s stock after purchasing an additional 34,507 shares during the period. Vestor Capital LLC’s holdings in Intuitive Surgical were worth $18,722,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Beaumont Financial Advisors LLC grew its holdings in shares of Intuitive Surgical by 3.8% in the 3rd quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock worth $255,000 after acquiring an additional 23 shares during the period. Hughes Financial Services LLC increased its position in Intuitive Surgical by 40.7% during the third quarter. Hughes Financial Services LLC now owns 83 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 24 shares in the last quarter. W.G. Shaheen & Associates DBA Whitney & Co increased its position in Intuitive Surgical by 1.0% during the 1st quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock worth $1,172,000 after purchasing an additional 25 shares in the last quarter. Blue Fin Capital Inc. grew its holdings in shares of Intuitive Surgical by 0.5% during the first quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock worth $2,210,000 after buying an additional 25 shares in the last quarter. Finally, Red Spruce Capital LLC grew its holdings in shares of Intuitive Surgical by 4.1% during the second quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider’s stock worth $255,000 after buying an additional 25 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have weighed in on ISRG. Oppenheimer reissued an “outperform” rating and set a $500.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 21st. JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $450.00 to $475.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 21st. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Wednesday, October 21st. Leerink Partners set a $503.00 target price on Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday, October 21st. Finally, Piper Sandler restated an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $493.54.

Insiders Place Their Bets

In other news, Director Craig Barratt sold 1,150 shares of the company’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $510,370.00. Following the completion of the transaction, the director directly owned 1,150 shares in the company, valued at approximately $510,370. This represents a 50.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the business’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the completion of the transaction, the vice president owned 1,026 shares in the company, valued at $464,993.46. This represents a 79.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 39,056 shares of company stock valued at $17,585,864. Corporate insiders own 0.60% of the company’s stock.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Revenue grew 22%, and the company placed 546 da Vinci systems in the third quarter of 2026. The article notes that system placements support a larger installed base, while instruments and services generate much of Intuitive Surgical’s recurring revenue. Intuitive Surgical Placed 546 da Vinci Systems Last Quarter. Why Wall Street’s Sell-Off Misses the Point.
• Positive Sentiment: Robust procedure growth and adoption of the da Vinci 5 system have helped shares recover, according to a six-month review. ISRG Gains 7.8% in 6 Months: Will the Share Price Recovery Continue?
• Neutral Sentiment: Intuitive Surgical appeared on a published list of top healthcare stocks following the midterm elections. The inclusion reflects investor interest in the sector, but is not a company-specific business development. Why Intuitive Surgical (ISRG) Just Cracked the Top 10 Best Healthcare Stocks List
• Negative Sentiment: Growing competition, litigation costs and valuation concerns could weigh on the shares. One article also notes that ISRG remains down for the year despite strong revenue growth. Intuitive Surgical (ISRG) Just Grew Revenue 22%. Why Is the Stock Still Down This Year?

Intuitive Surgical Trading Up 1.7%

Shares of Intuitive Surgical stock opened at $460.56 on Tuesday. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The company has a fifty day moving average price of $411.69 and a 200 day moving average price of $431.58. The stock has a market cap of $159.65 billion, a price-to-earnings ratio of 55.69, a price-to-earnings-growth ratio of 3.32 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter last year, the firm earned $2.40 earnings per share. Analysts forecast that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.

Intuitive Surgical Company Profile